Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy

A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis

NCT04721808 ·Status: COMPLETED

Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients

NCT03440892 ·Status: UNKNOWN

Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis

NCT02528292 ·Status: UNKNOWN

Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis

NCT00963703 ·Status: COMPLETED ·Phase: NA

An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor

NCT01557348 ·Status: COMPLETED

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT01565122 ·Status: COMPLETED

A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

NCT01294722 ·Status: COMPLETED

A Study on Rheumatoid Arthritis Patients Treated With Rituximab

NCT02622503 ·Status: COMPLETED

Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3)

NCT00665626 ·Status: COMPLETED ·Phase: PHASE2

Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

NCT01643928 ·Status: COMPLETED ·Phase: NA

A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

NCT03789292 ·Status: COMPLETED ·Phase: PHASE3

Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

NCT01932372 ·Status: COMPLETED

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

NCT05814627 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)

NCT01075477 ·Status: COMPLETED

A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib

NCT03823378 ·Status: TERMINATED ·Phase: PHASE2

Post-marketing Observational Study in Subjects With Rheumatoid Arthritis

NCT00234884 ·Status: COMPLETED

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

NCT02534896 ·Status: TERMINATED ·Phase: PHASE3

Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics

NCT03964649 ·Status: COMPLETED

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

NCT02222493 ·Status: COMPLETED ·Phase: PHASE3

Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)

NCT02097524 ·Status: COMPLETED ·Phase: PHASE1

An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01543503 ·Status: COMPLETED

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics

NCT01636817 ·Status: TERMINATED ·Phase: PHASE2

A Retrospective, Observational Study of RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis

NCT01921478 ·Status: COMPLETED

Faecal Analyses in Spondyloarthritis Therapy

NCT03839862 ·Status: RECRUITING

A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis

NCT06418529 ·Status: COMPLETED